Medicare Enrolled

Dr. Patrick Marcus, MD

Cardiovascular Disease · Kirkland, WA
Low-engagement
12333 NE 130TH LN STE 320, Kirkland, WA 98034
4258990555
In practice since 2015 (11 years)
NPI: 1053706929 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marcus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marcus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marcus

Dr. Patrick Marcus is a cardiovascular disease specialist in Kirkland, WA, with 11 years of NPI registration.

Between the years covered by Open Payments, Dr. Marcus received a total of $26,708 from 43 pharmaceutical and/or device companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marcus is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice $26,708 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$26,708
Total received (2020-2024)
Avg $5,342/year across 5 years
Top 7% in WA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
417
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,026 (90.0%)
Scientific / Research
Research funding and grants
$2,405 (9.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$278 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,196
2023
$9,091
2022
$3,975
2021
$3,549
2020
$897

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$2,802
Abbott Laboratories
$2,153
Medtronic, Inc.
$1,682
Penumbra, Inc.
$1,314
Terumo Medical Corporation
$238
ShockWave Medical, Inc
$195
Boston Scientific Corporation
$151
W. L. Gore & Associates, Inc.
$120
Teleflex LLC
$113
PFIZER INC.
$80
Bard Peripheral Vascular, Inc.
$64
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$40
Amgen Inc.
$36
CARDIVA MEDICAL, INC.
$31
Actelion Pharmaceuticals US, Inc.
$30
Novartis Pharmaceuticals Corporation
$29
CVRx, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Medline Industries LP
$19
Contego Medical, Inc
$18
Janssen Pharmaceuticals, Inc
$16
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 72.2% of 2024 payments
All-time payments by company (2020-2024) ›
Abbott Laboratories
$7,906
Medtronic, Inc.
$4,354
Edwards Lifesciences Corporation
$2,802
ABIOMED
$1,412
Penumbra, Inc.
$1,314
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,019
Inari Medical, Inc.
$934
Actelion Pharmaceuticals US, Inc.
$790
W. L. Gore & Associates, Inc.
$660
AstraZeneca Pharmaceuticals LP
$446
Impulse Dynamics (USA) Inc.
$413
Astellas Pharma US Inc
$405
PFIZER INC.
$377
Cardiovascular Systems Inc.
$373
Terumo Medical Corporation
$342
Teleflex LLC
$308
ShockWave Medical, Inc
$303
Boston Scientific Corporation
$283
Amgen Inc.
$246
Philips Electronics North America Corporation
$229
Novartis Pharmaceuticals Corporation
$193
Avinger Inc.
$143
AngioDynamics, Inc.
$139
Bard Peripheral Vascular, Inc.
$128
United Therapeutics Corporation
$125
Esperion Therapeutics, Inc.
$125
Janssen Pharmaceuticals, Inc
$115
Chiesi USA, Inc.
$115
SANOFI-AVENTIS U.S. LLC
$102
GENZYME CORPORATION
$97
CARDIVA MEDICAL, INC.
$93
Saranas, Inc.
$88
Medtronic Vascular, Inc.
$62
CHIESI USA, INC.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
CVRx, Inc.
$29
Lexicon Pharmaceuticals, Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$27
CORDIS US CORP.
$24
Kiniksa Pharmaceuticals, Ltd.
$22
Shockwave Medical, Inc
$21
Medline Industries LP
$19
Contego Medical, Inc
$18
Top 3 companies account for 56.4% of all-time payments
Associated products mentioned in payments ›
(6574) Coronary Other · (9520) IGT Devices Und · (9520) IGT Devices Undivided · ABSOLUTE PRO · ALPHAVAC · AMPLATZER Occluders · AZURE XT DR MRI SURESCAN · Advisa · Arcalyst · BRILINTA · Barostim Neo System · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CLEVIPREX 50MG/100ML · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CardioMEMS HF System · CareLink · Comet · Crosser iQ · DIAMONDBACK CORONARY · DRAGONFLY OPSTAR · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBOSHIELD NAV6 · ENTRESTO · EXCLUDER Conformable AAA Endoprosthesis with Active Control · EnSite Precision Cardiac Mapping System · FABRAZYME · FARXIGA · FLOWTRIEVER CATHETER · GLIDESHEATH SLENDER · GORE CARDIOFORM Septal Occluder · HEARTMATE TOUCH · HeartMate Touch · HeartWare HVAD · Impella · Inc. · Indigo System · Inpefa · JARDIANCE · JETI · JETI PERIPHERAL CATHETER · JETSTREAM SC · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LifeVest · MANTA · MANTA Vascular Closure Device · METACROSS OTW · MICRA · MULTAQ · Medline Industries · Micra · NEXLIZET · ONYX FRONTIER · OPSUMIT · OPTIMIZER · OPTIS · ORENITRAM · OUTBACK Elite · Optimizer · PANTHERIS · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · RESOLUTE ONYX · ROTAPRO · Ranger · Repatha · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TRAPLINER · TURNPIKE · UPTRAVI · VYNDAQEL · VenaSeal · Venclose Maven Catheter · WAINUA · WATCHMAN FLX · Wolverine Coronary Cutting Balloon · XACT · XARELTO · XIENCE SKYPOINT
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for cardiovascular disease in WA.

Looking for a cardiovascular disease specialist in Kirkland?
Compare cardiologists in the Kirkland area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
255
Per 100K population
11.3
County median income
$122,148
Nearest hospital
EVERGREENHEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marcus is a cardiovascular disease specialist, with low-engagement industry engagement in the top 7% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Marcus receive payments from pharmaceutical companies?
Yes. Dr. Marcus received a total of $26,708 from 43 companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Marcus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →